8/20/2021 Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study Chung H, He S, Nasreen S, Sundaram ME, Buchan SA, Wilson SE, Chen B, Calzavara A, Fell DB, Austin PC, Wilson K, Schwartz KL, Brown KA, Gubbay JB, Basta NE, Mahmud SM, Righolt CH, Svenson LW, MacDonald SE, Janjua NZ, Tadrous M, Kwong JC; on behalf of the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. BMJ. 2021; 374:n1943. Epub 2021 Aug 20. DOI: doi: https://doi.org/10.1136/bmj.n1943
7/23/2021 Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments Sundaram M, Nasreen S, Calzavara A, He S, Chung H, Bronskill SE, Buchan SA, Tadrous M, Tanuseputro P, Wilson K, Wilson S, Kwong JC; Canadian Immunization Research Network (CIRN) investigators. Vaccine. 2021; 39(37):5265-70. Epub 2021 Jul 23. DOI: https://doi.org/10.1016/j.vaccine.2021.07.060
3/13/2021 Vaccine coverage among children with epilepsy in two Canadian provinces: a Canadian immunization research network study Righolt CH, Pabla G, Donelle J, Brna P, Deeks SL, Wilson SE, Smith B, Wilson K, Mahmud SM, Top KA, Hawken S. Vaccine. 2021; 39(15):2117-23. Epub 2021 Mar 13. DOI: https://doi.org/10.1016/j.vaccine.2021.03.009